A detailed history of Boston Trust Walden Corp transactions in Globus Medical Inc stock. As of the latest transaction made, Boston Trust Walden Corp holds 729,924 shares of GMED stock, worth $60.9 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares
729,924
Previous 748,129 2.43%
Holding current value
$60.9 Million
Previous $51.2 Million 1.91%
% of portfolio
0.37%
Previous 0.38%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$67.08 - $73.92 $1.22 Million - $1.35 Million
-18,205 Reduced 2.43%
729,924 $52.2 Million
Q2 2024

Jul 19, 2024

SELL
$49.79 - $68.85 $30,322 - $41,929
-609 Reduced 0.08%
748,129 $51.2 Million
Q1 2024

Apr 22, 2024

SELL
$51.15 - $56.52 $65,625 - $72,515
-1,283 Reduced 0.17%
748,738 $40.2 Million
Q4 2023

Jan 24, 2024

BUY
$43.79 - $55.14 $95,155 - $119,819
2,173 Added 0.29%
750,021 $40 Million
Q3 2023

Oct 18, 2023

BUY
$49.1 - $62.37 $2.29 Million - $2.91 Million
46,580 Added 6.64%
747,848 $37.1 Million
Q2 2023

Jul 24, 2023

BUY
$52.61 - $59.54 $1.09 Million - $1.24 Million
20,751 Added 3.05%
701,268 $41.8 Million
Q1 2023

Apr 19, 2023

BUY
$51.83 - $79.63 $958,958 - $1.47 Million
18,502 Added 2.79%
680,517 $38.5 Million
Q4 2022

Jan 20, 2023

SELL
$58.4 - $75.53 $182,091 - $235,502
-3,118 Reduced 0.47%
662,015 $0
Q3 2022

Oct 19, 2022

BUY
$55.32 - $67.54 $1.27 Million - $1.55 Million
22,893 Added 3.56%
665,133 $39.6 Million
Q2 2022

Jul 22, 2022

BUY
$53.08 - $81.37 $319,753 - $490,172
6,024 Added 0.95%
642,240 $36.1 Million
Q1 2022

Apr 20, 2022

BUY
$63.68 - $75.54 $9.5 Million - $11.3 Million
149,126 Added 30.62%
636,216 $46.9 Million
Q4 2021

Jan 21, 2022

SELL
$62.62 - $79.92 $184,415 - $235,364
-2,945 Reduced 0.6%
487,090 $35.2 Million
Q3 2021

Oct 25, 2021

BUY
$76.41 - $84.06 $750,422 - $825,553
9,821 Added 2.05%
490,035 $37.5 Million
Q2 2021

Jul 22, 2021

SELL
$61.85 - $77.53 $1.24 Million - $1.55 Million
-20,009 Reduced 4.0%
480,214 $37.2 Million
Q1 2021

Apr 21, 2021

SELL
$60.05 - $67.74 $356,516 - $402,172
-5,937 Reduced 1.17%
500,223 $30.8 Million
Q4 2020

Jan 15, 2021

BUY
$48.89 - $65.87 $48,841 - $65,804
999 Added 0.2%
506,160 $33 Million
Q3 2020

Oct 14, 2020

BUY
$45.26 - $57.82 $1 Million - $1.28 Million
22,152 Added 4.59%
505,161 $25 Million
Q2 2020

Jul 23, 2020

BUY
$39.81 - $55.61 $1.6 Million - $2.24 Million
40,220 Added 9.08%
483,009 $23 Million
Q1 2020

Apr 24, 2020

SELL
$35.06 - $59.45 $3.07 Million - $5.21 Million
-87,564 Reduced 16.51%
442,789 $18.8 Million
Q1 2020

Apr 21, 2020

BUY
$35.06 - $59.45 $3.48 Million - $5.89 Million
99,144 Added 22.99%
530,353 $22.6 Million
Q4 2019

Jan 10, 2020

BUY
$49.45 - $59.5 $391,495 - $471,061
7,917 Added 1.87%
431,209 $25.4 Million
Q3 2019

Oct 21, 2019

BUY
$40.41 - $52.32 $4.78 Million - $6.19 Million
118,336 Added 38.8%
423,292 $21.6 Million
Q2 2019

Jul 25, 2019

BUY
$39.3 - $48.41 $100,136 - $123,348
2,548 Added 0.84%
304,956 $12.9 Million
Q1 2019

Apr 16, 2019

BUY
$38.08 - $49.41 $58,985 - $76,536
1,549 Added 0.51%
302,408 $14.9 Million
Q4 2018

Jan 17, 2019

SELL
$41.38 - $57.44 $467,180 - $648,497
-11,290 Reduced 3.62%
300,859 $13 Million
Q3 2018

Oct 23, 2018

SELL
$50.24 - $56.76 $990,381 - $1.12 Million
-19,713 Reduced 5.94%
312,149 $17.7 Million
Q2 2018

Jul 25, 2018

SELL
$47.96 - $57.41 $411,496 - $492,577
-8,580 Reduced 2.52%
331,862 $16.7 Million
Q1 2018

Apr 13, 2018

SELL
$42.75 - $51.73 $1.08 Million - $1.3 Million
-25,171 Reduced 6.88%
340,442 $17 Million
Q4 2017

Jan 29, 2018

SELL
$28.86 - $41.64 $280,750 - $405,073
-9,728 Reduced 2.59%
365,613 $15 Million
Q3 2017

Oct 13, 2017

BUY
$28.28 - $30.85 $10.6 Million - $11.6 Million
375,341
375,341 $11.2 Million

Others Institutions Holding GMED

About GLOBUS MEDICAL INC


  • Ticker GMED
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 77,037,200
  • Market Cap $6.43B
  • Description
  • Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devi...
More about GMED
Track This Portfolio

Track Boston Trust Walden Corp Portfolio

Follow Boston Trust Walden Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Trust Walden Corp, based on Form 13F filings with the SEC.

News

Stay updated on Boston Trust Walden Corp with notifications on news.